Result of AGM

Sinclair Pharma plc

Result of AGM

13 June 2018, Sinclair Pharma plc (AIM: SPH.L), the international aesthetics company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

For further information, please contact:

Sinclair Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner 

Alan Olby

Andy Crane

Peel Hunt LLP (NOMAD and Joint Broker) Tel: +44 (0) 20 7418 8900 James Steel

Oliver Jackson

RBC Capital Markets (Joint Broker) Tel: +44 (0) 20 7653 4000

Marcus Jackson

Media enquiries

FTI Consulting Tel: +44 (0) 20 3727 1000

Ben Atwell

Brett Pollard

Notes to Editors:

About Sinclair Pharma plc 

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, self-pay global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets, Brazil, South Korea and the US, and has a network of international distributors.